KDM1A and lung cancer: In the mouse model of lung cancer, LSD1 inhibitor (SP2509) increased H3K9me3 level and predominantly inhibit the proliferation of lung cancer cells with menin-low expression, supporting that decreased H3K9me3 was a risk factor in lung cancer [43].